Antibody

7개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved7 programs
AntibodyCurated CoreFDAEli LillyApproved

lebrikizumab-lbkz (Ebglyss, LY3650150, lebrikizumab)

Moderate-to-severe atopic dermatitis · IL-13

#IL-13#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 108Status Approved
AntibodyCurated CoreFDAAstraZenecaApproved

tezepelumab (Tezspire, AMG 157, MEDI9929, tezepelumab-ekko)

Severe asthma add-on maintenance, chronic rhinosinusitis with nasal polyps · TSLP (thymic stromal lymphopoietin)

#TSLPthymicstromallymphopoietin#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 47Status Approved
AntibodyLimited DatastaleImmunityBio, Inc.Phase 2

NAI (Nogapendekin Alfa-Inbakicept, Nogapendekin Alfa-Inbakicept (NAI))

Acute Respiratory Distress Syndrome; Severe Community-Acquired Pneum · Acute Respiratory Distress Syndrome

#AcuteRespiratoryDistressSyndrome#Antibody#Phase2#monoclonal-antibody#SevereCommunity-AcquiredPneum+2
Trials 46Status Discontinued
AntibodyLimited DatastaleNovartisPhase 3

Experimental: Secukinumab high dose (Experimental: Secukinumab high dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#monoclonal-antibody#Novartis
Trials 2Status Active
AntibodyLimited DatastaleRochePhase 2

Administration of rituximab and methylprednisolone (Administration of rituximab and methylprednisolone)

Early and Severe Systemic Sclerosis · Early and Severe Systemic Sclerosis

#EarlyandSevereSystemicSclerosis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleBiocon Biologics UK LtdPhase 3

Bmab1200 (Bmab1200)

Moderate to Severe Chronic Plaque Psoriasis · Moderate to Severe Chronic Plaque Psoria

#ModeratetoSevereChronicPlaquePso#Antibody#Phase3#monoclonal-antibody#Biocon
Trials 1Status Active
AntibodyLimited DatastaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#monoclonal-antibody#Sanofi
Trials 1Status Recruiting